Posted by UlarSawa > 2020-12-11 15:24 | Report Abuse

vaccine is not long term investment but bamboo is. dont miss up the two. Vaccine is one off item. it will end very fast. bamboo is long term. I do not promote kanger base on vaccine. I see no future in vaccine as there are 5 china vaccines available. imagine all are approved by MOH. what profit are you talking now. negligible. I hate to see vaccine become centre attraction of kanger. correct?

Posted by NPRA1985 > 2020-12-11 15:26 | Report Abuse

@tinghn As i said, i am NOT part of the management so i do not know why they made that mistake. If you want to know further, go and visit Kanger officer in Malaysia and query them. Like i said, the ADDRESS IS THE SAME. If you think its fake then you can choose not to enter, your money your decision. I am here for the long term....

Posted by NPRA1985 > 2020-12-11 15:27 | Report Abuse

@UlarSawa Yes, i agree with you. Vaccine is just supplementary profit. The bamboo core business is the CASH COW that will generate most of the profits for the company.

Posted by bowman > 2020-12-11 15:30 | Report Abuse

MoU is not binding.

Posted by lamy92 > 2020-12-11 15:33 | Report Abuse

Run now... Gambling only

Posted by kasrim > 2020-12-11 15:35 | Report Abuse

the beast will release soon..

Posted by NPRA1985 > 2020-12-11 15:36 | Report Abuse

@lamy92 Thanks for your concern...

Posted by BigBladd > 2020-12-11 15:36 | Report Abuse

Kanger International Bhd (KIB) has inked a COLLARBORATION AGREEMENT with China-based Sinopharm Group Hunan Changde Medical Co Ltd (Sinopharm Group) for the distribution of Covid-19 vaccines developed by China National Biotech Group Company (CNBG) in Malaysia.

COLLABORATION AGREEMENT meaning (A collaboration agreement is a legally binding agreement between different parties that want to co-operate together or work collaboratively on a commercial project that sets out how the parties will work together, divides the benefits, responsibilities and obligations created by or for the project between the parties...)

Posted by NPRA1985 > 2020-12-11 15:47 | Report Abuse

I calculated the average price of private placement shares based on the number of shares issued and price at each tranche of private placement ie. 0.163. Hence,If it closes at 0.160, it is a bad sign.

Based on my limited knowledge of private placement, the company management by right should not allow the share price to drop below the average private placement share price because IF it were to happen, that would mean that there will be no incentive for the 3rd party investor to invest in the private placements shares when they can just purchase the share from the open market

Hence by logic, 0.165 would be a strong support. However, if i am am wrong and the price drops below 0.165, then it is a bad sign....

Posted by NPRA1985 > 2020-12-11 15:49 | Report Abuse

And i really hope that Kanger would be transparent enough to reveal the 3rd party investor(s) of the private placement shares soon...

Posted by bowman > 2020-12-11 15:57 | Report Abuse

If my guess is right, this is as low as it gets. If it breaches the 200MA, then it will close at 0.14 - which is bad for the party to which it placed its shares privately.

Posted by Noobie123 > 2020-12-11 15:59 | Report Abuse

@chua..as i see it

Like I said before, bamboo is cash cow, vaccine is shining star. Cash cows provide daily operating income, high volume, steady income on a long term basis. Bamboo is the bread butter cash cow business. Rental income from hotel and autocity is also cash cow.

Shining stars are high margin opportunistic products. Vaccine is the shining star. It would start at 3rd mth lasting into 6 to 12 months before vaccine run is over. Of course if it is approved.
Is Sinopharm true or not? I cannot tell you 100%, but from desk research, it is the best info we have to say it is true. I do not base what rumors or allegations without basis in my analysis.

What if all these fell through? Well..all is not lost as we still have the cash cow businesses and Kanger assets are all there eg hotel and autocity both land and building, new R&D center, 2 new factories, land in Malaysia and not forgetting its patented bamboo products and marketing network.
0.17 will not turn into zero value. Neither this company would turn into a PN17.

So why would we talk about vaccine and not bamboo now? Simply vaccine is the low hanging fruits with high potential in the immediate future. Bamboo production results come out only in 1Q 2021. What's there to talk? But feel free to contribute whatever is beneficial bamboo or vaccine.

I am here on long term, I put my money where my thoughts is. So I hope my fellow investors here do not try to teach each another how to invest. We are all here for the best returns. We share what we know. Remember a rising tide lift all boats. Happy investing. Good luck to all.

Posted by NPRA1985 > 2020-12-11 16:01 | Report Abuse

@bowman Hence, i doubt the company management will allow the share price to drop below average private placement price of 0.163. It would not make any sense to attract 3rd party investors when they can just buy the shares from the open market...

Posted by kenie > 2020-12-11 16:02 | Report Abuse

Every country government only buy Pfizer vaccines

Posted by NPRA1985 > 2020-12-11 16:03 | Report Abuse

@Noobie123 Well said. Totally agree with you....

Posted by NPRA1985 > 2020-12-11 16:05 | Report Abuse

@Kenie Malaysia has already signed the vaccine agreement with China. So like it or not, Chinese vaccine will be one of the choices that our government will be acquiring. However, as for now, Kanger will only be distributing the vaccines to private sector.

Posted by NPRA1985 > 2020-12-11 16:07 | Report Abuse

10% - Covax
20% - Pfizer

So 70% (herd immunity) - 10% - 20% = 40% of the Malaysian population still unaccounted for by the government...

Posted by NPRA1985 > 2020-12-11 16:27 | Report Abuse

With regards to COVAX which will be covering 10% of the Malaysian population, i believe the government will most probably select AstraZeneca vaccine as it is currently the only western vaccine available via COVAX. Even if Moderna vaccine joins COVAX later on, Malaysia will most certainly not select it as it is using the same vaccine technology/ platform as Pfizer vaccine ie mRNA vaccine

----------------------

AstraZeneca is the only one to have already struck a deal with COVAX, a global initiative to distribute COVID-19 vaccines equitably, including to low-income nations, according to data from the Duke Global Health Innovation Center.

COVAX has placed an order for 300 million doses from AstraZeneca. Meanwhile, Pfizer-BioNTech isn't part of the COVAX initiative, and Moderna is part of the COVAX project, but has not "quite aligned with them on how many doses and when those doses would be available," according to Axios.

https://www.businessinsider.com/how-covid-vaccines-compare-cost-astrazeneca-oxford-pfizer-biontech-moderna-2020-11

Posted by NPRA1985 > 2020-12-11 16:36 | Report Abuse

From the looks of it, Kanger will close at 0.165 today....As long as it doesn't drop below 0.165, i am contented for now...

Posted by bowman > 2020-12-11 16:41 | Report Abuse

@NPRA1985 10% - Covax

Malaysia strives to acquire herd immunity when 70% of the population is innoculated, I believe. If you take the population as 35mil, It will need to vaccinate about 25mil people. That is the number of doses (x2) that the country will need, assuming it goes for the Pfizer model. I doubt Pfizer can supply all that. So, it will be also through Covax. Now, if you can roughly estimate how much Pfizer and Covax can supply, then the figure left will be that from China's Sinopharm. Now, this is by no mean conclusive estimate of how much of the vaccine will be distributed by Kanger. As I said earlier, its investor relations team sucks big time.

Posted by joni > 2020-12-11 16:42 | Report Abuse

TODAY CLOSE 17C monday higher

Posted by Noobie123 > 2020-12-11 16:48 | Report Abuse

Just use 10% of pop will do as it is for private use. That means 3.5m people x RM200 both doses= RM700m. What profit margin?

Posted by DrHash > 2020-12-11 16:50 | Report Abuse

And I thought we will stay away for 3days from here hahaha

Posted by DrHash > 2020-12-11 16:51 | Report Abuse

Noobie my TP got lower... Rm 3.60now

Posted by DrHash > 2020-12-11 16:51 | Report Abuse

Hahaha

Posted by Noobie123 > 2020-12-11 16:52 | Report Abuse

DrHash...I not so greedy. RM2 will do for me. Hahahaha

Posted by my2020 > 2020-12-11 16:55 | Report Abuse

RM1 is good for me :)

Posted by NPRA1985 > 2020-12-11 16:55 | Report Abuse

@joni No today close at 0.165....Keeping it real...

Posted by NPRA1985 > 2020-12-11 16:58 | Report Abuse

I have already made a promise to myself, if it drops below private placement price of 0.163, i will leave...0.165 is the lowest i am willing to accept based on that private placement price...However, if it remains above 0.165, i will keep for long term....

Posted by my2020 > 2020-12-11 17:00 | Report Abuse

yup. TA shows already oversold, and will sideway until good news come out. hold tight!

Posted by 18KHarmoni > 2020-12-11 17:02 | Report Abuse

Dont give up NPRA. Stay until Q1 2021, u will be rewarded. We need u to update the info

Posted by my2020 > 2020-12-11 17:02 | Report Abuse

http://www.sinopharm.com/en/1398.html

Sinopharm owns over 1,100 subsidiaries and 6 listed companies which are Sinopharm Group Co., Ltd. (Sinopharm Holding), China National Medicines Corporation Ltd., China National Accord Medicines Corporation Ltd., Beijing Tiantan Biological Products Co., Ltd., Shanghai Shyndec Pharmaceutical Co., Ltd., and China Traditional Chinese Medicine Holdings Co., Ltd.

Posted by Noobie123 > 2020-12-11 17:04 | Report Abuse

At least keep until China announce vaccine approval and take it from there

Posted by NPRA1985 > 2020-12-11 17:05 | Report Abuse

@18KHarmoni I highly doubt it will drop below 0.165...So no worries...

Posted by Noobie123 > 2020-12-11 17:07 | Report Abuse

NPRA, my average is higher than yours..u run, I also run lor

Posted by jutawansenyap > 2020-12-11 17:11 | Report Abuse

Finally mention about leaving.kah kah kah.
Let me tell you.16.5cents is a fake q.Thats all.kekeke

Posted by jutawansenyap > 2020-12-11 17:15 | Report Abuse

Dont leave.Bursa need people like you to buy higher.Burn money.

Posted by NPRA1985 > 2020-12-11 17:24 | Report Abuse

@jutawansenyap What makes you think that i bought at high price. Your assumptions make you look stupider than a moron. Your Prlexus is the biggest joke. Price is going down despite anticipation of good QR....

Posted by UlarSawa > 2020-12-11 17:24 | Report Abuse

now no more talking about covid vaccine. New antibody drug is more superior than vaccine is on phase 3 trial. correct?


https://www.malaymail.com/news/singapore/2020/12/11/singapore-biotech-firm-tychan-starts-final-phase-of-covid-19-antibody-drug/1931058

Posted by UlarSawa > 2020-12-11 17:25 | Report Abuse

MOH staff. vaccine is dead soon. when antibody drug is out. correct?

Posted by NPRA1985 > 2020-12-11 17:26 | Report Abuse

@UlarSawa. Vaccine is for prevention of infection whereas antibody is for cure once you have already been infected. 2 different things. As doctors always say, prevention is better than cure...

Posted by UlarSawa > 2020-12-11 17:27 | Report Abuse

Vaccines alone not enough

When asked how the antibody drug differs from a vaccine, Prof Ooi said that a vaccine alone would not get rid of Covid-19.

For example, he noted that the protection a vaccine offers against the disease is about 95 per cent. That means there is still a chance for vaccinated individuals to contract the virus.

Furthermore, vaccination may not be suitable for patients undergoing cancer treatment or those with a history of allergies.

“Moreover, we do not know how long the protection from vaccines will last. At some point, as the vaccine immunity wanes, there is a chance that Covid-19 could reappear,” he said.

It is thus important to have both forms of treatment.

An antibody drug will allow those unable to be vaccinated to be protected in some way, said Prof Ooi.

He does not foresee issues mass-producing TY027, as the technology for such production of antibody drugs is mature, compared with new vaccine production.

“To really tackle this problem of a re-emergence of a Covid-19 epidemic... having treatment (with antibody drugs) for Covid-19 that really drives the virus load down, so that we do not get severe disease, is still important to prevent our healthcare system from being choked up with severe cases.” — TODAY

Posted by NPRA1985 > 2020-12-11 17:29 | Report Abuse

@jutawansenyap Besides, Prlexus follows glove theme. Most of the institutions have already withdrawn from glove counters and moved on to recovery theme stocks. What is left in glove counters are mostly retailers...Its the end of glove and face mask counters for now.. The sentiment has died...

Posted by UlarSawa > 2020-12-11 17:29 | Report Abuse

if you do not get covid 19 why need to be vaccinated with few months old vaccine? better wait for new antibody drug to come out. do t get vaccinated with not proven record vaccine. correct?

Posted by NPRA1985 > 2020-12-11 17:35 | Report Abuse

@UlarSawa Of course vaccine alone is not enough. Vaccine is extremely important and will play a huge role in achieving herd immunity. Antibody is just to supplement vaccines because as you know vaccine efficacy is NOT 100%. Furthermore, NOT 100% of the population will opt for vaccination. Hence, despite vaccination, there will bound to be a small number of infections lingering amongst the population. Hence, antibody treatment still has a role and "fills that gap" to treat those unlucky few in the population that got infected.

If it werent for vaccines, polio would not have been able to be eradicated globally. You should thank vaccines for that...

Posted by NPRA1985 > 2020-12-11 17:36 | Report Abuse

@UlarSawa You sound like an anti-vaxxer here based on your illogical arguments...

Posted by NPRA1985 > 2020-12-11 17:37 | Report Abuse

Thank god the number of anti-vaxxers in Malaysia are few.. Otherwise, we will not be able to achieve the target herd immunity of 70%...

Posted by Fong Kh > 2020-12-11 17:40 | Report Abuse

Kanger chart shows a downtrend

Posted by NPRA1985 > 2020-12-11 17:43 | Report Abuse

@Fong Kh Yes you are right but it seems to have settled at 0.165... Lets see what happens next week...Only time can tell..

Posted by Fong Kh > 2020-12-11 17:44 | Report Abuse

0.13 can top up if it hits this level